Search & Analyze
Popular Searches
Akums Drugs & Pharmaceuticals Ltd.
Healthcare₹682.850.96%
24 Jul, 4:01 PM
CMP₹682.85
Mkt Cap₹10.95K Cr
P/E42.90
P/B3.30
ROE8.06%
52W High₹713.80
52W Low₹410.10
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
42.90
P/B Ratio
3.30
EV/EBITDA
14.35
Price/Sales
2.51
Dividend Yield (%)
0.43
EPS (TTM ₹)
16.21
Book Value (₹)
210.57
ROE (%)
8.06
ROCE (%)
14.77
ROA (%)
5.59
EBITDA Margin (%)
11.98
Net Profit Margin (%)
5.88
Debt/Equity
0.02
Current Ratio
3.25
Interest Coverage
5.06
Asset Turnover
0.95
Working Capital/Sales
1.77
Core EBITDA Growth (%)
25.97
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 36718.93 | 36548.2 | 41781.82 | 41181.58 | 43590.17 |
| Net Sales | 36718.93 | 36548.2 | 41781.82 | 41181.58 | 43590.17 |
| Total Income | 36945.23 | 37448.94 | 42122.07 | 41741.47 | 44877.42 |
| Total Expenditure | 37636.12 | 33608.39 | 40551.97 | 36575.45 | 38369.93 |
| Operating Profit | -690.89 | 3840.55 | 1570.1 | 5166.02 | 6507.49 |
| Depreciation | 946.79 | 1128.09 | 1256.4 | 1534.46 | 1545.51 |
| Exceptional Items | -129.77 | -745 | -260.34 | 166.97 | -200.24 |
| Profit Before Tax | -1931.97 | 1502.97 | -452.78 | 3452.53 | 3821.01 |
| Tax | 576.77 | 524.8 | -460.68 | 14.76 | 1257.04 |
| Profit After Tax (PAT) | -2508.74 | 978.17 | 7.9 | 3437.77 | 2563.97 |
| EPS (₹) | -17.65 | 6.63 | -0.28 | 22.6 | 16.67 |
| Dividend Payout % | — | — | — | — | 150 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 143.07 | 286.13 | 286.13 | 306.21 | 306.21 |
| Reserves | 6076.69 | 6885.76 | 6808.85 | 30163.93 | 32827.27 |
| Shareholders Funds | 6219.76 | 7171.89 | 7094.98 | 30470.14 | 33133.48 |
| Total Debt | 3579.53 | 5369.73 | 4915.55 | 136.55 | 729.54 |
| Total Liabilities | 30501.95 | 32350.1 | 33933.02 | 39053.77 | 52760.77 |
| Total Assets | 30501.95 | 32350.1 | 33933.02 | 39053.77 | 52760.77 |
| Book Value / Share | 86.9471 | 50.1303 | 49.5927 | 199.0147 | 216.4102 |
| Assets | 30501.95 | 32350.1 | 33933.02 | 39053.77 | 52760.77 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 318.54 | 1766.31 | 4982.59 | 4651.96 | 11812.02 |
| Investing Activities | -2348.22 | -3047.02 | -3304.15 | -5478.43 | -9302.68 |
| Financing Activities | 2360.4 | 1245.4 | -1080.21 | 727.88 | 338.8 |
| Net Cash Flow | 330.72 | -35.31 | 598.23 | -98.59 | 2848.14 |
AKUMS
₹682.85
-0.96%